LADENBURG THALMANN FINANCIAL SERVICES INC. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 184 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$7,0000.0%113
-7.4%
0.00%
Q3 2019$7,000
+250.0%
122
+190.5%
0.00%
Q2 2019$2,0000.0%420.0%0.00%
Q1 2019$2,000
-33.3%
42
-44.0%
0.00%
Q4 2018$3,000
-70.0%
75
-47.2%
0.00%
Q3 2018$10,000
-94.4%
142
-95.8%
0.00%
-100.0%
Q2 2018$178,0000.0%3,3990.0%0.00%0.0%
Q1 2018$178,000
-0.6%
3,399
+1.5%
0.00%0.0%
Q4 2017$179,000
-11.8%
3,3490.0%0.00%0.0%
Q3 2017$203,000
-22.2%
3,349
+0.9%
0.00%
-33.3%
Q2 2017$261,000
-4.7%
3,318
+0.5%
0.00%0.0%
Q1 2017$274,000
+4.6%
3,3000.0%0.00%
-25.0%
Q4 2016$262,000
+13.4%
3,3000.0%0.00%
+33.3%
Q3 2016$231,000
+75.0%
3,300
-1.5%
0.00%
+50.0%
Q2 2016$132,000
+6500.0%
3,350
+6600.0%
0.00%
Q1 2016$2,000
-50.0%
500.0%0.00%
Q4 2015$4,000
-87.9%
50
-87.7%
0.00%
-100.0%
Q2 2015$33,0004050.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders